Anavex Life Sciences
AVXL
$3.58
Share price
3.92%
Change (1 day)
-56.08%
Change (1 year)
Categories
EPS for Anavex Life Sciences (AVXL)
EPS in 2023 (TTM): -$0.66
According to Anavex Life Sciences 's latest financial reports the company's current EPS (TTM) is -$0.66. In 2022 the company made an earnings per share (EPS) of -$0.65 a decrease over its 2021 EPS that were of -$0.55.
EPS history for Anavex Life Sciences from 2005 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.66 | 1.54% |
| 2022 | -$0.65 | 18.18% |
| 2021 | -$0.55 | 22.22% |
| 2020 | -$0.45 | -11.76% |
| 2019 | -$0.51 | 10.87% |
| 2018 | -$0.46 | 35.29% |
| 2017 | -$0.34 | -10.53% |
| 2016 | -$0.38 | -39.41% |
| 2015 | -$0.63 | -45.94% |
| 2014 | -$1.16 | 180.17% |
| 2013 | -$0.41 | -50.71% |
| 2012 | -$0.84 | -22.22% |
| 2011 | -$1.08 | -28.95% |
| 2010 | -$1.52 | 58.33% |
| 2009 | -$0.96 | -11.11% |
| 2008 | -$1.08 | 107.69% |
| 2007 | -$0.52 | |
| 2006 | N/A | -100% |
| 2005 | -$0.01542 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Ligand Pharmaceuticals LGND | $1.57 | -337.88% | 🇺🇸 USA |
 Corcept Therapeutics
CORT | $0.88 | -233.33% | 🇺🇸 USA |
 Palatin Technologies PTN | -$2.96 | 348.48% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | -$1.25 | 89.39% | 🇺🇸 USA |